BD SafetyGlide™ 0.5 mL 29G 12.7 mm Insulin Syringe Pack of 100

Becton Dickinson

Medical device

Safety insulin syringe with fixed needle

CE marked medical device, Class IIa (Directive 93/42/EEC), CE 0050 (per BD technical documentation covering BD SafetyGlide™ insulin syringes including ref. 305932)
Conforms to ISO 8537: Sterile single Use syringes for insulin
Conforms to ISO 7864: Sterile hypodermic needles for single use
Conforms to ISO 9626: Stainless steel needle tubing for the manufacture of medical devices
Conforms to EN 1041: Information supplied by the manufacturer of medical devices
Sterile, single Use device
Latex Free

CE marked medical device, Class IIa (Directive 93/42/EEC), CE 0050 (per BD technical documentation covering BD SafetyGlide™ insulin syringes including ref. 305932)
Conforms to ISO 8537: Sterile single Use syringes for insulin
Conforms to ISO 7864: Sterile hypodermic needles for single use
Conforms to ISO 9626: Stainless steel needle tubing for the manufacture of medical devices
Conforms to EN 1041: Information supplied by the manufacturer of medical devices
Sterile, single Use device
Latex Free

Safety insulin syringe with fixed needle

Description

BD SafetyGlide™ 0.5 mL 29G 12.7 mm Insulin Syringes are sterile, single-use safety-engineered insulin syringes with a permanently attached 29G (0.33 mm) needle and U-100 insulin graduations. The integrated sliding SafetyGlide™ shield is activated with one hand immediately after injection, helping protect healthcare professionals and caregivers from accidental needlestick injuries while maintaining patient comfort. The syringes are latex-free, supplied in individual blister packs, and intended for subcutaneous injection of U-100 insulin. Each box contains 100 syringes; BD catalog reference 305932.

Bnefits

Safety-engineered sliding shield designed to reduce needlestick injury risk
One-handed safety activation with minimal change in injection technique
Permanently attached 29G x 1/2 in (12.7 mm) stainless steel needle for subcutaneous insulin delivery
U-100 insulin graduations for accurate insulin dosing up to 0.5 mL (50 IU)
Latex-free construction to reduce risk of latex-related hypersensitivity
Sterile, single-use device to help prevent cross-contamination
Regular-wall, regular-bevel needle designed for smooth skin penetration
Individually blister-packed for aseptic presentation
Recognised BD brand quality with technical data sheet and IFU support

Indications

Subcutaneous injection of U-100 insulin using a 0.5 mL insulin syringe
Use in patients requiring insulin therapy for diabetes, in clinical or home-care settings
Settings where safety-engineered sharps devices are recommended to reduce needlestick risk (e.g. hospitals, clinics, primary care, diabetes clinics, medical aesthetics practices treating insulin-dependent patients)

Composition

Barrel: plastic syringe body (medical-grade polymer)
Plunger: plastic plunger with elastomeric stopper
Needle: stainless steel, 29G (external diameter 29G, length 13 mm / 0.5 in)
Needle wall type: regular wall
Needle tip type: regular bevel for subcutaneous injection
Integrated BD SafetyGlide™ sliding safety shield attached to the needle hub
Latex-free components
Sterile product supplied in individual blister packaging

Formulation

Device type: sterile safety insulin syringe with permanently attached needle
Fill volume: 0.5 mL (50 IU U-100 scale)
Graduations: U-100 insulin units
Needle gauge and length: 29G x 1/2 in (0.33 mm x 13 mm, 12.7 mm nominal)
Needle application: subcutaneous injection

Packaging

Primary packaging: individual sterile blister pack per syringe
Shelf box: 100 syringes per box
Shipping case (manufacturer configuration): 400 syringes (4 boxes of 100) per shipping carton (per BD technical data sheet)
Blister pack labelling includes product identification, gauge, length and U-100 insulin scale
Retail listing: Pack of 100 syringes

Usage

Verify product details (volume 0.5 mL, 29G x 12.7 mm, U-100 insulin) on the packaging before use.
Inspect the blister pack; do not use if the package is damaged, opened or the sterility is compromised.
Open the blister aseptically and remove the sterile syringe immediately before use.
Draw up the prescribed dose of U-100 insulin using the U-100 unit scale on the barrel.
For subcutaneous injection, prepare the injection site according to local protocol (e.g. clean skin and allow to dry).
Pinch or gently lift the skin fold if required and insert the needle subcutaneously (29G x 12.7 mm) at an appropriate angle (commonly 90° or as per clinical guidance).
Depress the plunger fully to deliver the full insulin dose.
While withdrawing the needle from the patient, activate the BD SafetyGlide™ shield using the one-handed activation technique recommended in the BD instructions (slide or press the shield forward until it locks with an audible or tactile click).
Confirm that the safety shield is locked over the needle and the needle tip is fully covered.
Immediately discard the used, shielded syringe into an approved sharps disposal container; do not recap, bend or manually remove the needle.
Do not reuse; this is a sterile, single-use device.

Contraindications

Not publicly listed

Adverse Effects

Not publicly listed

Storage Conditions

Store in a clean, dry environment at room temperature as indicated on the packaging.
Keep syringes in their original packaging until use to maintain sterility.
Protect from excessive heat, moisture and direct sunlight.
Keep out of reach of children and unauthorised users.